There are 169 resources available
Currently available targeted therapies in BTC: Unmet needs
Presenter: Angela Lamarca
Session: Diving into hepatobiliary malignancies
Resources:
Slides
Webcast
New targets for precision medicine in BTC: Where are we going?
Presenter: Antoine Hollebecque
Session: Diving into hepatobiliary malignancies
Resources:
Slides
Webcast
Minimal residual disease as a surrogate for early drug development
Presenter: Davide Rossi
Session: Surrogate endpoints in early phase drug development
Resources:
Slides
Webcast
New targeted therapies and IO approaches in hepatobiliary malignancies
Presenter: Jordi Rodon
Session: Diving into hepatobiliary malignancies
Resources:
Slides
Webcast
Panel discussion
Presenter: All Speakers
Session: Surrogate endpoints in early phase drug development
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Diving into hepatobiliary malignancies
Resources:
Webcast
Beyond CD3 bispecifics: Activating NK cells, CD40, CD137
Presenter: Juanita Lopez
Session: Bispecific therapeutics: Moving into the fast lane
Resources:
Slides
Webcast
MRD testing: Evidence for clinical validity and utility
Presenter: Umberto Malapelle
Session: ctDNA applications
Resources:
Slides
Webcast
ctDNA in drug development: Maximising utility
Presenter: Daniel Shao Weng Tan
Session: ctDNA applications
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: ctDNA applications
Resources:
Webcast